Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Plos One|May 30, 2014
Impact of platelet transfusion on survival of patients with intracerebral hemorrhage after administration of anti-platelet agents at a tertiary emergency centerYuhko Suzuki, Takao Kitahara, Kazui Soma, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 3, 2024
Prognostic factors for overall survival in clinical node-positive patients with upper tract urothelial carcinomaTaishiro Sasahara, Takafumi Yanagisawa, Shingo Sugaya, et al.
Inflammation and Regeneration|January 18, 2026
Pivotal contribution of super-enhancer-driven KLF6 expression to the adipogenesis of human adipose-derived stem cellsMai-Phuong Nguyen, Kaoru Yamagata, Anh Phuong Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral artery occlusion in miceDidrik S Frydenlund, Anish Bhardwaj, Takashi Otsuka, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2006
Poly(ADP-ribose) (PAR) polymer is a death signalShaida A Andrabi, No Soo Kim, Seong-Woon Yu, et al.
The Prostate|September 24, 2021
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancerTakafumi Yanagisawa, Takahiro Kimura, Keiichiro Mori, et al.
The Prostate|January 20, 2023
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapyTakafumi Yanagisawa, Kenichi Hata, Shintaro Narita, et al.
Urologic Oncology|May 19, 2026
Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPCShuhei Hara, Keiichiro Mori, Ryotaro Yamaguchi, et al.
Clinical Genitourinary Cancer|April 15, 2026
Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter StudyShuhei Hara, Keiichiro Mori, Masaki Hashimoto, et al.
World Journal of Urology|May 21, 2022
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysisTakafumi Yanagisawa, Takahiro Kimura, Kenichi Hata, et al.
Pageof 7